A care optimization platform that helps patients, providers and health plans navigate substance use disorder (SUD) has raised $15 million in Series C funding.
The money will be used to accelerate axialHealthcare’s expansion into the SUD treatment and recovery sector, according to a press release announcing the news.
Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP) and Sandbox Advantage Fund led the funding round.
Previously, axialHealthcare was largely focused on using its analytics for early prevention and risk mitigation. While it will continue to pursue those goals, axialHealthcare will also put new focus on helping people already struggling with opioid use disorder.
“This funding will support the market launch of an end-to-end platform that offers personalized solutions from risk to recovery, with a new emphasis on connecting and aligning what is a fractured ecosystem for recovery,” axialHealthcare CEO Carter Paine said in the press release. “In collaboration with our client partners, we are devoted to finding a better way to support patients and families struggling with the complexities of SUD.”
As part of axialHealthcare’s treatment push, it will combine “high-tech” with “high-touch,” using technology, treatment professionals and peer recovery specialists to help those with OUD.
Additionally, the company unveiled new branding to go with its new focus.
Companies featured in this article:
